发明授权
- 专利标题： Heterocyclic compounds and uses thereof
- 专利标题（中）： 杂环化合物及其用途
-
申请号： US13396339申请日： 2012-02-14
-
公开(公告)号： US08865732B2公开(公告)日： 2014-10-21
- 发明人: Zilin Huang , Jeff Jin , Timothy Machajewski , William R. Antonios-McCrea , Maureen McKenna , Daniel Poon , Paul A. Renhowe , Martin Sendzik , Cynthia Shafer , Aaron Smith , Yongjin Xu , Qiong Zhang , Zheng Chen
- 申请人： Zilin Huang , Jeff Jin , Timothy Machajewski , William R. Antonios-McCrea , Maureen McKenna , Daniel Poon , Paul A. Renhowe , Martin Sendzik , Cynthia Shafer , Aaron Smith , Yongjin Xu , Qiong Zhang , Zheng Chen
- 申请人地址： CH Basel
- 专利权人： Novartis AG
- 当前专利权人： Novartis AG
- 当前专利权人地址： CH Basel
- 代理商 Scott W. Reid
- 主分类号： A61K31/505
- IPC分类号： A61K31/505 ; C07D241/02
摘要：
New substituted heterocyclic compounds, compositions containing them, and methods of using them for the inhibition of Raf kinase activity are provided. The new compounds and compositions may be used either alone or in combination with at least one additional agent for the treatment of a Raf kinase mediated disorder, such as cancer.
公开/授权文献
- US20130210818A1 Novel Heterocyclic Compounds and Uses Thereof 公开/授权日：2013-08-15
信息查询
